FDA Approved: DAUNORUBICIN HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for daunorubicin hydrochloride (Hikma Pharmaceuticals USA Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Daunorubicin hydrochloride (daunorubicin hydrochloride)

Snippet

SUPPL AP for DAUNORUBICIN HYDROCHLORIDE (DAUNORUBICIN HYDROCHLORIDE)